rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
1998-10-1
|
pubmed:abstractText |
Specific and selective alpha2-adrenergic drugs are widely exploited in veterinary anesthesiology. Because alpha2-agonists are also being introduced to human practice, the authors studied reversal of a clinically relevant dexmedetomidine dose with atipamezole, an alpha2-antagonist, in healthy persons.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0003-3022
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
89
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
574-84
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:9743392-Adrenergic alpha-Antagonists,
pubmed-meshheading:9743392-Adult,
pubmed-meshheading:9743392-Blood Pressure,
pubmed-meshheading:9743392-Cross-Over Studies,
pubmed-meshheading:9743392-Dose-Response Relationship, Drug,
pubmed-meshheading:9743392-Double-Blind Method,
pubmed-meshheading:9743392-Heart Rate,
pubmed-meshheading:9743392-Humans,
pubmed-meshheading:9743392-Hypnotics and Sedatives,
pubmed-meshheading:9743392-Imidazoles,
pubmed-meshheading:9743392-Male,
pubmed-meshheading:9743392-Medetomidine,
pubmed-meshheading:9743392-Norepinephrine,
pubmed-meshheading:9743392-Receptors, Adrenergic, alpha-2,
pubmed-meshheading:9743392-Sympatholytics
|
pubmed:year |
1998
|
pubmed:articleTitle |
Reversal of the sedative and sympatholytic effects of dexmedetomidine with a specific alpha2-adrenoceptor antagonist atipamezole: a pharmacodynamic and kinetic study in healthy volunteers.
|
pubmed:affiliation |
Department of Anesthesiology, Turku University Hospital, Finland. harry.scheinin@utu.fi
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|